News
Rupert Resources Reports Further Drilling From Ikkari Extending Mineralisation in the West and Below 450m
Rupert Resources Ltd (“Rupert” or “the Company”, TSX-V: RUP) reports new drill results from its Ikkari prospect, the focus of its ongoing exploration programme at the 100% owned Pahtavaara Project
Preclinical Data from ImmunoPrecise’s Drug Pipeline to be Presented During the BIO International Partnering Event
IMMUNOPRECISE ANTIBODIES LTD (the "Company" or "IPA") (NASDAQ: IPA) (TSX VENTURE: IPA) today announced the results from in vitro characterizations investigating TATX-21, a novel potential
Gold Reserve Completes Sale of Shares to 401(k) Plan
Gold Reserve Inc. (TSX.V:GRZ) (OTCQX:GDRZF) (the “Company”) announces that it completed a previously announced, non-brokered private placement to Rockne Timm, Douglas Belanger and Robert
Tokens.com Publishes a Letter to Shareholders Regarding its Staking Operations Powering the Next Generation of Finance
Tokens.com Corp. (NEO: COIN) (FSE: 76M) (“Tokens.com” or the “Company”), a Blockchain technology company that provides transaction processing and validation services for various digital assets that
ImmunoPrecise Announces Appointment of Dr. Ilse Roodink to the Role of Chief Scientific Officer and Resignation of Dr. Yasmina Abdiche
IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (NASDAQ: IPA) (TSX VENTURE: IPA) a leader in full-service, therapeutic antibody discovery and development, announced today that Dr. Yasmina
Tokens.com Publishes a Letter to Shareholders Regarding its Near Zero-Energy Consumption Crypto Business
Tokens.com Corp. (NEO: COIN) (FSE: 76M) (“Tokens.com” or the “Company”) publishes a letter to shareholders regarding the Company’s business model, particularly as it relates to energy consumption.
Gold Reserve Announces Sale of Shares to 401(k) Plan
Gold Reserve Inc. (TSX.V:GRZ) (OTCQB:GDRZF) (the “Company”) announces that it plans, subject to the approval of the TSX Venture Exchange (the “TSXV”), a non-brokered private placement to Rockne
Lomiko Metals CEO Speaks on the Electric Vehicle Revolution at the Emerging Growth Conference on May 26, 2021
Lomiko Metals Inc. (TSX-V: LMR, OTC: LMRMF, FSE: DH8C) (Lomiko or the “Company”) invites individuals, institutional investors, advisors and analysts to attend its real-time, interactive
ImmunoPrecise Names Dr. Dion Neame to Strategic Advisory Board
IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (NASDAQ: IPA) (TSX VENTURE: IPA) a leader in full-service, therapeutic antibody discovery and development, today announced that Dr. Dion Neame
Tokens.com Purchases Additional Operating Assets
Tokens.com Corp. (NEO:COIN) (FSE:76M) (“Tokens.com” or “the Company”) is a blockchain technology company that provides transaction processing and validation services for various digital assets that
ImmunoPrecise Moves SARS-CoV-2 PolyTope™ Cocktail Program’s Path Toward IND Filing
ImmunoPrecise Antibodies Ltd. (the "Company" or "IPA") (NASDAQ: IPA) (TSX venture: IPA) announces the completion of an efficacy-driven, preclinical study demonstrating further evidence of the in
Gold Reserve Announces Cost Reduction Program and Stock Option Grants
Gold Reserve Inc. (TSX.V:GRZ) (OTCQB:GDRZF) ("Gold Reserve" or the "Company") announces that its Board of Directors has approved a three-year cost reduction program to decrease cash operating costs
Lomiko to Explore for Lithium on Bourier Project Optioned From Critical Elements
Lomiko Metals Inc. (TSX-V: LMR, OTC: LMRMF, FSE: DH8C) (Lomiko or the “Company”) and Critical Elements Lithium Corporation (TSX-V: CRE) (US OTCQX: CRECF) (FSE: F12) ("Critical Elements" or the "Com
A Paul Gill, Lomiko CEO Speaks at Edward Snowden ‘On the Record’ Event at the Private Investment Club Conference
Lomiko Metals Inc. (TSX-V: LMR, OTC: LMRMF, FSE: DH8C) (Lomiko or the “Company”) announces CEO A. Paul Gill will speak at the Edward Snowden - On the Record Virtual Conference hosted by the Private
Rupert Resources Drills 4.4g/t Gold Over 188m From 64m Including 8.9g/t Au Over 23m and 3.8g/t Over 141m From 30m Including 8.2g/t Au Over 49m at Ikkari
Rupert Resources Ltd (“Rupert” or “the Company”) reports new drill results from its Ikkari prospect, the focus of its ongoing 60,000m exploration programme at the 100% owned Pahtavaara Project in
ImmunoPrecise Launches TATX-112 Candidate Antibody Program, for the Treatment of Cancer and Alzheimer’s Disease
IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (NASDAQ: IPA) (TSX VENTURE: IPA) a leader in full-service, therapeutic antibody discovery and development, today announced that its subsidiary
Lomiko La Loutre Metallurgical Testing Produces Concentrate Grading 97.8% Carbon and 93.5% Graphite Recovery
Lomiko Metals Inc. (TSX-V: LMR, OTC: LMRMF, FSE: DH8C) (Lomiko or the “Company”) is pleased to provide an update on its La Loutre graphite project (“La Loutre”), located in Quebec, Canada. La
Rupert Resources Drills 6.1 g/t Gold Over 110m From 183.6m and Reports Positive Results From Further Metallurgical Testwork at Ikkari
Rupert Resources Ltd (“Rupert” or “the Company”) reports new drill results from its Ikkari prospect, the focus of its ongoing 60,000m exploration programme at the 100% owned Pahtavaara Project in
Lomiko Selects Ausenco for La Loutre PEA
Lomiko Metals Inc. (TSX-V: LMR, OTC: LMRMF, FSE: DH8C) (Lomiko or the “Company”) is pleased to announce the selection of Ausenco Engineering Canada Inc. (“Ausenco”) as the lead study consultant to
ImmunoPrecise Identifies a Unique Antibody, 23-H7, That Demonstrates In Vivo Efficacy, an Alternative Mechanism of Action and Binds all Tested SARS-CoV-2 Variants of Concern
IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (NASDAQ: IPA) (TSX VENTURE: IPA) a leader in full-service, therapeutic antibody discovery and development, today announced the identification
Lomiko Hires BRIDGE© for Community Relations
Lomiko Metals Inc. (TSX-V: LMR, OTC: LMRMF, FSE: DH8C) (Lomiko or the “Company”) is pleased to announce that it has retained BRIDGE©, and its principal and founder Siri C. Genik, to provide
ImmunoPrecise Reports Financial Results and Recent Business Highlights for Third Quarter of 2021 Fiscal Year
IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (NASDAQ: IPA) (TSX VENTURE: IPA) a leader in full-service, therapeutic antibody discovery and development, today announced financial results
Rupert Resources Drills 3.6 G/t Gold Over 169m at Ikkari Including a High-grade Zone of 21.7g/t Gold Over 5m at Depth
Rupert Resources Ltd (“Rupert” or “the Company”) reports new drill results from its Ikkari prospect, the focus of its ongoing 60,000m exploration programme at the 100% owned Pahtavaara Project in
ImmunoPrecise Antibodies Announces Results from a Comprehensive Screening of 27 Proprietary Anti-SARS-CoV-2 Therapeutic Antibodies
IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (NASDAQ: IPA) (TSX VENTURE: IPA) a leader in full-service, therapeutic antibody discovery and development, today has confirmed the results of
Lomiko Hires New York-Based Veritas Consulting Group Inc. for Investor Relations
Lomiko Metals Inc. (TSX-V: LMR, OTC: LMRMF, FSE: DH8C) (the “Company”) announces that is has retained Veritas Consulting Group Inc. of New York to provide Investor Relations Services accordance